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Abstract  
This study evaluated the antimicrobial property of the aqueous extract of Citrullus lanatus 
(watermelon) seeds and its concentration-effect relationship (time-kill studies) on typed bacterial and 
fungal strains. Crude powdered seeds of Citrullus lanatus were extracted by maceration with water. 
Antimicrobial assay of the aqueous extracts was determined against Bacillus subtilis (NCTC 8236), 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 10145), Staphylococcus aureus 
(ATCC 25923), and Candida albicans (ATCC 24433) using standard microbiological methods. A total 
of 106 CFU/mL of each test strain was used as a baseline to carry out the time-kill studies. Extract 
concentration at minimum inhibitory concentration (MIC), 2MIC and 4MIC were used over a period of 
24 hours. Aqueous extract had an intermediate antibacterial activity with inhibition zone diameters 
(IZD) of 15 - 18 mm and MIC range of 2.5 - 20 mg/mL. Time-kill studies showed a bacteriostatic, non-
concentration dependent mode of antimicrobial activity with characteristic regrowth for all test strains. 
Citrullus lanatus seeds aqueous extract exhibited antimicrobial activity with a bacteriostatic, non-
concentration dependent mode of action against test bacterial strains. Further studies aimed at 
isolating and purifying the antimicrobial principle in the aqueous extract of C. lanatus seed is 
warranted as this could serve as a potential new antibiotic for treating microbial infections. 
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The ability of an antimicrobial agent to inhibit 
or kill a microbe is often evaluated by a time -
kill study also known as pharmacodynamics 
study. Pharmacodynamics is the study of the 
biochemical and physiological effects of drugs 
(pharmaceutical or herbal). These effects can 
include those manifested within animals, 
humans, microorganisms or combination of 
organisms. It is often summarized as a dose-
response relationship as seen by the 
relationships between drug concentration and 
its effects (Englehardt and Chiu, 2019). 
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Pharmacodynamic effect of an antimicrobial 
agent can be determined by studying the 
bacterial growth and death patterns following 
its administration in vitro. Ethical issues make 
it difficult to carry out this type of studies in 
humans and animal model. Thus, in 
vitro systems play a pivotal role in 
understanding the concentration-effect 
relationship of antimicrobial agents (Tonoyan 
et al., 2017). The resultant time-kill curves 
show a clear relationship between the extent 
of antimicrobial activity and the concentration 
of the agent with respect to time (Li et al., 
2017). Thus time-kill studies can determine the 
bactericidal or bacteriostatic activity of an 
agent over time. A lethality effect of 90 % in six 
hours or 99.9 % in twenty-four hours is 
considered as a bactericidal mechanism of 
action (Konate et al., 2012). Antimicrobial 
activity of an agent may also be considered 
bactericidal if the MBC/MIC ratio is equal four. 
In contrast, MBC of bacteriostatic agents is 
many folds greater than MIC (Keepers et al., 
2014). This lethality effect is said to be a 
concentration-dependent killing when cell 
death increases with increase in concentration 
of the agent. Antimicrobials of plant origin have 
enjoyed widespread application in the 
management of bacterial infections in Nigeria. 
However, optimization of dosage regimen has 
been a major challenge to the safe and 
efficacious use of these crude agents (Moore, 
2018). Often times the minimum inhibitory 
concentration (MIC) is the only parameter 
used in the development of antimicrobial 
treatment regimen (Pohl et al., 2018). 
Results obtained from the in vitro 
pharmacodynamic studies of an antimicrobial 
can provide better insight that could be used to 
optimize dosage regimen and help prevent 
treatment failures (Foster et al., 2016). This 
assay provides descriptive information on the 
pharmacodynamics of an antimicrobial agent 
on susceptible bacteria strains. This study 
examined the pharmacodynamic relationship 
between varying concentrations of aqueous 
extract of C. lanatus seeds, microbial growth 
and death rate of four typed bacteria strain and 
a fungal strain, namely; Bacillus subtilis (NCTC 
8236), Escherichia coli (ATCC 25922),   
Pseudomonas aeruginosa (ATCC 10145), 
Staphylococcus aureus (ATCC 25923), and 
Candida albicans (ATCC 24433) using 
standard microbiological methods. This is with 
a view to optimize dosage regimen and 
prevent possible treatment failures associated 
with the use of herbal remedies. 
Watermelon (Citrullus lanatus) belong to the 
cucurbitaceae family. It is an annual fruit plant 
that is globular to oblong in shape and grown 
on trailing vines of about 4.6 m in length. A 
longitudinal section of the fruit shows an outer 
rind, a layer of white pulp and an interior edible 
pulp containing seeds, a few varieties are 
seedless. The crushed seeds made into an 
emulsion has been used to treat catarrh, bowel 
disorders, fever and as an anti-helminthic 
agent (Adedeji, 2018). In Nigeria, the seeds 
are used to treat gastrointestinal and urinary 
tract infections and the rind is used in 
treatment of diabetes, hypertension and to 
conceal blemishes from acne (Erhirhie and 
Ekene, 2013). Apart from the medicinal uses 
of watermelon, it is also a source of food and 
few reports exist on its potential as a source of 
phytochemicals and nutrients (Maoto et al., 
2019). 
 




Ciprofloxacin powder (Sigma Aldrich, 
Taufkirchen, Germany), ketoconazole 
(Biochemika, Mumbai, India), dimethyl 
sulphoxide (DMSO) (JHD Science-Tech Co., 
China) were used in the study. Fresh fruits of 
Citrullus lanatus used for this study were 
obtained from Tamboga market in Benin City, 
Edo State, Nigeria and identified by a 
taxonomist at the Department of Plant Biology 
and Biotechnology, Faculty of Life Sciences, 
University of Benin, Benin City. A voucher 





Preparation of crude extracts 
 
The fruits were cleaned with water, seeds 
were extracted, rinsed and air dried for five 
days. The seeds were pulverized using a 
kitchen blender (Kenwood BL460, England) 
and about 1.0 kg of the powdered seeds was 
macerated with distilled water for 48 hours. 
The resultant solution was clarified using 
Whatman filter paper No. 1. The clarified 
filtrate was concentrated in a hot air oven at 45 
°C for 72 hours to obtain a dried aqueous 
extract which was weighed and kept at 4 °C in 
an airtight container until required for use 






Microorganisms used for this study were 
originally from American Type Culture 
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Collection (ATCC) United States of America. 
They were obtained from stock culture of the 
Department of Pharmaceutical Microbiology, 
Faculty of Pharmacy, University of Ibadan, 
Nigeria. Reference strains used in this study 
were Bacillus subtilis (NCTC 8236)), 
Escherichia coli (ATCC 25922), 
Staphylococcus aureus (ATCC 25923), 
Pseudomonas aeruginosa (ATCC 10145) and 
Candida albicans (ATCC 24433). 
 
Preparation of test microorganisms 
 
Test bacteria were sub-cultured from stock into 
sterile nutrient agar plates and incubated at 37 
°C for twenty-four hours. Sabouraud dextrose 
agar was used to subculture test fungus which 
was incubated at 35 °C for forty-eight hours. 
Following incubation, pure colonies were 
harvested and sub-cultured into sterile broth 
and incubated for twelve hours. This was 
standardized to 0.5 McFarland to give an 
inoculum size of approximately 108 CFU/mL. 
The standard inoculum was diluted 1:100 to 
give inoculum size of 106 CFU/mL using the 
M07-A10 approved guideline (CLSI, 2015). 
 
Preparation of stock solutions 
 
Ciprofloxacin stock solution was prepared by 
dissolving 5.0 mg of ciprofloxacin powder in 10 
% DMSO solvent and making up the volume to 
10.0 mL, giving a final concentration of 0.5 
mg/mL while ketoconazole stock solution was 
prepared with 10.0 mg ketoconazole powder in 
10 % DMSO solvent to give a 1.0 mg/mL final 
concentration solution. A final concentrations 
of 1000 mg/mL stock solution of the seed 
extract was prepared by dissolving 1.0 g of 
extract in 1.0 mL of solvent (Babaiwa et al., 
2017). 
 
Antimicrobial susceptibility tests 
 
Using the agar well diffusion method of Murray 
et al. (1999) with some modifications, 
antimicrobial susceptibility tests were carried 
out. Standardized inoculum of each 
microorganism (200 µL) was mixed thoroughly 
with 30.0 mL of sterile Mueller Hinton agar (45 
- 50 °C) poured into sterile Petri dishes and 
allowed to set. A sterile cork borer (10.0 mm) 
was used to bore six wells in each agar plate. 
The agar disks were removed and each of the 
sealed wells filled with 200 µL (equivalent to 
200 mg) of aqueous extracts of C. lanatus 
seeds. The same procedure was carried out 
with ciprofloxacin (0.5 mg/mL) and 
ketoconazole (1.0 mg/mL) where 200 µL was 
emptied into each well to give 0.1 mg (100 µg) 
and 0.2 mg (200 µg) per well, respectively. 
Negative control (10 % DMSO solution) and 
positive control (viability test for used 
organisms) were carried out for each set of 
experiment. Plates were incubated at 37 °C for 
18 - 24 hours for bacteria and at 35 °C for 48 
hours for Candida albicans. Diameters of 
zones of inhibition were measured in 
millimeters (mm) and used as an index of the 
inhibitory or killing action of the test agent 
against a given organism. Experiments were 
done in triplicates. 
 
Minimum inhibitory concentration (MIC) 
determination 
 
The minimum inhibitory concentration (MIC) of 
the extract and test agents (ciprofloxacin and 
ketoconazole) on susceptible microorganisms 
was determined using the agar well dilution 
method of Afolayan and Meyer (1997). 
Following the manufacturer's instructions, 
nutrient and Sabouraud agars were prepared 
separately by placing them in a hot water bath 
at 50 °C. Different volumes of the extract stock 
solution were introduced into the molten agar 
to obtain a concentrations range of 6.25 - 400 
mg/mL. Ciprofloxacin stock solution (0.5 
mg/mL) was serially diluted two folds, giving a 
concentration range of 5.0 - 0.015625 µg/mL. 
The concentration ranges for ketoconazole 
stock solution (1.0 mg/mL) were 200 - 0.2 
µg/mL. The nutrient agar-extract and nutrient 
agar-ciprofloxacin as well as the Sabouraud 
agar-ketoconazole mixtures were introduced 
separately into sterile plates and allowed to set 
and then dried at 40 °C. Test bacteria were 
streaked onto the solidified agar-extract and 
agar-ciprofloxacin plates while test fungus was 
streaked onto the agar-extract and agar-
ketoconazole plates. Each set of experiments 
had a negative (10 % DMSO solution) and a 
positive (viability test for used organisms) 
control. The plates were incubated at 37 °C for 
18 - 24 hours while plates for C. albicans were 
incubated at 35 °C for 48 hours. Experiments 
were done in triplicates. The lowest 
concentration of the extract or ciprofloxacin or 
ketoconazole that inhibited growth of the test 
microorganisms was taken as the MIC.  
 
Minimum bactericidal/fungicidal 
concentration (MBC/MFC) determination 
 
Following the MIC determination, plates 
showing no visible growth were swabbed and 
streaked onto freshly prepared Mueller Hinton 
agar plates already containing the same 
predetermined concentrations of extract or 
ciprofloxacin or ketoconazole. The plates for 
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bacteria were incubated at 37 °C for 18 - 24 
hours and those for fungus at 35 °C for 48 
hours. The lowest concentration that inhibited 
growth of test organisms for the extract and 
ciprofloxacin was taken as the MBC while the 
lowest concentration of ketoconazole that 
inhibited growth of the test fungus was 
recorded as the MFC.  
 
Time-kill studies of extract on susceptible 
microorganisms 
 
The time-kill studies were carried out using the 
broth macro dilution method of Okoli and 
Iroegbu (2005) with some modifications. Kill 
kinetics were done at MIC, 2MIC, and 4MIC 
(previously determined) of test 
microorganisms. These concentrations were 
developed in 2.0 mL tubes containing double 
strength nutrient broth. This was inoculated 
with 200 µL of test microorganism prepared by 
the colony suspension method previously 
described. The final inoculum density was 
approximately 105 CFU/mL. Positive control 
(viability test for used organisms) was carried 
out. The tubes were incubated in a shaker 
water bath at 37 °C for bacteria and at 35 °C 
for C. albicans for twenty-four hours. At 
various time intervals ranging from 0, 1, 2, 3, 
4, 5, 6 and 24 hours, approximately 100 µL 
from each sample was withdrawn and diluted 
tenfold in sterile normal saline (0.9 %w/v 
NaCl). About 100 µL of each dilution was 
plated in duplicate in sterile nutrient agar using 
the pour plate method. The plates were 
incubated for 24 hours at 37 °C for bacteria 
and 35 °C for C. albicans. Plates with 30 - 300 
colonies were counted with results expressed 





The extract obtained from the extractive 
process was brownish in colour with a 
percentage yield of 3.963 %. Results from the 
antimicrobial assay of the extract shown in 
Table 1 revealed that the test strains were 
susceptible to the inhibitory effect of the 
aqueous extract, standard ciprofloxacin and 
ketoconazole. An intermediate antimicrobial 
activity was observed for the extract against all 
test strains; with MIC range of 2.5 - 20.0 mg. 
This inhibitory effect was observed to be 
bacteriostatic against all test strains and the 
MIC doses produced the highest inhibitory 
activity when compared to other 
concentrations (2MIC and 4MIC). The extract 
induced a more rapid kill on the Gram positive 
bacteria (Staphylococcus and Bacillus 
species) with a characteristic steep 
pharmacodynamic time kill curve at 4MIC 
(Figures 1 and 2) while a reduced inhibitory 
response was observed for Gram negative E. 
coli, with periods of regrowth associated with 
P. aeruginosa (Figures 3 and 4). The extract at 
4MIC was unable to reduce the number of C. 
albicans and Gram-negative survivors to zero 
in 24 hours of assay (Figures 3, 4 and 5). This 
is suggestive of a bacteriostatic mechanism of 
action against these microbes. 
 
 












Pseudomonas aeruginosa (ATCC 10145) 17.0 ± 0.13 33.0 ± 0.14 NA 
Escherichia coli (ATCC 25922) 16.0 ± 0.11 38.0 ± 0.03 NA 
Bacillus subtilis (NCTC 8236) 16.0 ± 0.01 35.0 ± 0.23 NA 
Staphylococcus aureus (ATCC 25923) 15.0 ± 0.21 30.0 ± 0.21 NA 







Pseudomonas aeruginosa (ATCC 10145) 2.0 × 104 ± 0.003 0.25 ± 0.001 NA 
Escherichia coli (ATCC 25922) 2.5 × 104 ± 0.002 0.0625 ± 0.002 NA 
Bacillus subtilis (NCTC 8236) 2.5 × 104 ± 0.004 0.125 ± 0.010 NA 
Staphylococcus aureus (ATCC 25923) 2.0 × 104 ± 0.001 0.25 ± 0.001 NA 











Pseudomonas aeruginosa (ATCC 10145) > 2.0 × 104 0.25 ± 0.001 NA 
Escherichia coli (ATCC 25922) 5.0 × 104 ± 0.002 0.0625 ± 0.002 NA 
Bacillus subtilis (NCTC 8236) 5.0 × 104 ± 0.004 0.125 ± 0.010 NA 
Staphylococcus aureus (ATCC 25923) > 2.0 × 104 0.25 ± 0.001 NA 
Candida albicans (ATCC 24433) > 2.0 × 104 NA 10.0 ± 0.02 
 
Key: IZD (Inhibition zone diameter), MIC (Minimum inhibitory concentration), MBC/MFC (Minimum bactericidal/fungicidal 
concentration), NA (Not applicable), Values ± SEM 






























The water maceration process of extraction 
gave a low percentage yield of the extract. The 
low extractive capacity of water observed may 
probably be due to the low solubility of the 
major components of the seeds in water. It has 
been reported that the seed contains about 
41.84 % of fat, 28.05 % of carbohydrate and 
21.46 % of proteins (Egbuonu, 2015). 
The extract had an intermediate antimicrobial 
activity with inhibition zone diameters (IZD) of 
15 - 18 mm. Existing literature has reported 
the inhibitory activity of C. lanatus seed extract 
against some Gram positive and Gram-
negative bacteria (Braide et al., 2012). Results 
from our study is also in line with the study of 
Hassan et al., (2011), who demonstrated the 
inhibitory activity of this seed against 
Aspergillus niger and yeast. Inhibition zone 
diameters of this extract against test strains 
were observed to be small. This may be partly 
due to interference from impurities commonly 
associated with crude extracts. Ciprofloxacin 
and ketoconazole had larger inhibition zone 
diameters against test bacteria and fungus 
respectively. This is consistent with pure 
compounds. Time-kill curve of the aqueous 
extract against Staphylococcus aureus, 
showed an initial decrease in cell number in 
the first hour of the experiment. This may be 
due to the rapid death of susceptible cells in 
the population. As previous reports have 
documented that colonies of bacterium exist 
as mixed population with varied susceptibilities 
(Shao et al., 2017). This observed regrowth 
during the third hour of the experiment may be 
due to rapid kill of susceptible subpopulation 
coupled with amplification of resistant cells 
(Drusano et al., 2014). Rate of kill of 
Staphylococcus aureus by this extract showed 
no linear relationship with concentration over 
time; as there was no significant difference in 
the kill rate of 2MIC and 4MIC. Suggesting that 
an increase in concentration of the extract may 
not translate to increase in its kill rate 
The kill pattern of the aqueous extract on 
Bacillus subtilis cells from the sixth hour 
(Figure 2) to the 24th hour of the experiment 
was bacteriostatic. This inhibitory effect may 
be due to reversible inhibition of enzyme 
systems, uncoupling of transport systems and 
possibly permeability changes within the 
affected cells. There was no significant 
difference in the antibacterial effect produced 
at MIC, 2MIC and 4MIC (p > 0.05). The 
standard drug, ciprofloxacin exhibited high 
bactericidal activity against Bacillus subtilis 
from the beginning of the experiment reducing 
viable cell numbers to zero at the twenty forth 
hour. This may be due to the fact that 
ciprofloxacin is in its pure form and contains no 
extraneous substances that could interfere 
with its antibacterial action. 
Steady reduction in viable cell number of 
Pseudomonas aeruginosa (Figure 3), from the 
fourth to the twenty fifth hour of the experiment 
at MIC is considered to be bacteriostatic. This 
may be due to the irreversible damage to 
cellular organelles and/or cellular pathways 
that are essential for the survival and growth of 
Pseudomonas aeruginosa. This extract has 
shown a concentration independent 
bactericidal activity against the test bacterium. 
Viable number of Escherichia coli and Candida 
albicans cells were observed to decrease 
slowly in the first five hours of the experiment 
(Figures 4 and 5) with a percentage death of 
25.0 % each. This percentage lethality is 
however less than 90.0 % lethality required for 
bactericidal effect (Konate et al., 2012). Thus, 
the extract investigated in this study has 
shown a bacteriostatic activity against these 
strains. A steady regrowth was seen beyond 
the fifth up to the twenty forth hour. This initial 
decrease in viable number may be due to 
reversible damage caused by the extract to 
cellular components and also interference with 
some cellular pathways. The observed 
regrowth could be due to the ability of the 
organism to effect repairs of it damage 
component and possibly bye pass cellular 
pathways that the extract may have interfered 
with. There was no significant difference (p = 
0.275) between the rate of kill observed at 
MIC, 2MIC and 4MIC. 
Standard drug (ketoconazole) exhibited 
fungicidal activity from the beginning of the 
experiment reducing viable cell number 
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significantly by the twenty forth hour of the 
experiment. This high antifungal activity is 




The outcome of time-kill studies based on 
MIC, 2MIC and 4MIC values have shown that 
the aqueous extract of C. lanatus seeds 
possessed a bacteriostatic, non-concentration 
dependent mode of action against test 
bacterial and fungus strains. Thus, there is a 
need to isolate and purify the antimicrobial 
principle in the aqueous extract of C. lanatus 
seed as this could serve as a potential new 
antibiotic. 
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